Overview
Status
Active
Registry date
2013-07-22
Share capital
10,000.00 PLN
Registered address
Powstańców Śląskich 25, 45-087 Opole, Poland
Financials
Revenue history (in k)
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 305 days for 2023).
- 202522/09/2026
- 202404/11/2025
- 202316/05/2025
- 202218/08/2023
- 202105/07/2022
- 202005/07/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 78.27kMedianUSD 178.92kAverageUSD 6.85m
Net profit
This companyUSD 20.57kMedianUSD 2.73kAverageUSD 464.86k
Operating costs
This companyUSD 52.57kMedianUSD 175.18kAverageUSD 6.09m
Assets
This companyUSD 100.10kMedianUSD 160.35kAverageUSD 5.64m
Industry
Authorized Representatives
Roman Furmaniak – President of the Management Board
Marta Mieleszkiewicz – Attorney-in-fact (sole)
Manner of representation
A member of the management board jointly with a commercial proxy is authorized to make declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Roman Furmaniakage 59 | 97 | $2,620.21 | 97% |
Others | 3 | $81.04 | 3% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 6, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezydent Miasta Opole |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FDLsp. z o.o. | $158,234.91 | fakdatlab.com | ||
| Eryngiumsp. z o.o. | $110,141.40 | eryngium.pl | ||
| Pcschemiasp. z o.o. | $102,042.50 | pcschemia.com | ||
| GLOEsp. z o.o. | $93,527.31 | gloe.pl | ||
| Prospersp. z o.o. | $89,881.50 | mirakosmetyki.pl | ||
| Sunewmed+sp. z o.o. | $75,769.44 | sunew.pl | ||
| Reve De Chantellesp. z o.o. | $55,262.77 | revedechantelle.pl | ||
| By Corelsp. z o.o. | $46,678.56 | bycorel.com | ||
| Farmacia Verdesp. z o.o. | $41,891.92 | farmaciaverde.pl | ||
| Lupharm Laboratorysp. z o.o. | $34,484.58 | lupharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-10-19 | PKD change (Removed: 54 codes) | |
| 2013-07-22 | Entered in the register |
FAQ
The main business activity of Éclat focuses on manufacture of perfumes and toilet preparations.
The company was registered in the Polish National Court Register (KRS) on July 22, 2013.
The headquarters is located at: Powstańców Śląskich 25, 45-087 Opole.
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 78,265, representing an increase of 10.1% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 20,572, meaning the company decreased its profit by 22.6%.
The largest operating cost category falls under external services. This category amounted to USD 41,581 in 2025, representing 79% of all operating expenses.
Last updated: 2026-09-22
